We aspire to transform the lives of people living with lung cancer, the second most common cancer worldwide, by delivering meaningful advances to improve the treatment landscape and redefine all lung cancers as curable.
Latest Articles on Lung Cancer
Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, accounting for 80-85% of all lung cancer cases. Find out more about testing and treatment here.
The Bigger Picture of Treatment Sequencing
In this animated video, oncologist Dr Hochmair gives his unique insight into the EGFR M+ NSCLC treatment landscape, and explains why treatment sequencing is important to consider at the start of the patient journey.
Introduction to head-to-head trials
Hear from experts Dr Kerr and Dr Melosky.
Related Press Releases
September 02, 2020
Final analysis of the observational GioTag study: Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
March 16, 2020
New uncommon EGFR mutations database published featuring clinical outcomes of NSCLC patients treated with afatinib
Welcome to InOncology.com
A knowledge hub providing information and education in oncology for healthcare professionals.
Nintedanib (Vargatef) in Oncology
A treatment for adenocarcinoma
A treatment for EGFR M+ NSCLC
Nintedanib in Oncology
Explore nintedanib’s mode of action and role in the treatment of lung cancer (PDF).